These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

264 related items for PubMed ID: 19255022

  • 1. Randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of topiramate for migraine prevention in pediatric subjects 12 to 17 years of age.
    Lewis D, Winner P, Saper J, Ness S, Polverejan E, Wang S, Kurland CL, Nye J, Yuen E, Eerdekens M, Ford L.
    Pediatrics; 2009 Mar; 123(3):924-34. PubMed ID: 19255022
    [Abstract] [Full Text] [Related]

  • 2. Efficacy and safety of topiramate for the treatment of chronic migraine: a randomized, double-blind, placebo-controlled trial.
    Silberstein SD, Lipton RB, Dodick DW, Freitag FG, Ramadan N, Mathew N, Brandes JL, Bigal M, Saper J, Ascher S, Jordan DM, Greenberg SJ, Hulihan J, Topiramate Chronic Migraine Study Group.
    Headache; 2007 Feb; 47(2):170-80. PubMed ID: 17300356
    [Abstract] [Full Text] [Related]

  • 3. Topiramate for migraine prevention: a randomized controlled trial.
    Brandes JL, Saper JR, Diamond M, Couch JR, Lewis DW, Schmitt J, Neto W, Schwabe S, Jacobs D, MIGR-002 Study Group.
    JAMA; 2004 Feb 25; 291(8):965-73. PubMed ID: 14982912
    [Abstract] [Full Text] [Related]

  • 4. Topiramate for migraine prevention in children: a randomized, double-blind, placebo-controlled trial.
    Winner P, Pearlman EM, Linder SL, Jordan DM, Fisher AC, Hulihan J, Topiramate Pediatric Migraine Study Investigators.
    Headache; 2005 Feb 25; 45(10):1304-12. PubMed ID: 16324162
    [Abstract] [Full Text] [Related]

  • 5. Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study.
    Diener HC, Bussone G, Van Oene JC, Lahaye M, Schwalen S, Goadsby PJ, TOPMAT-MIG-201(TOP-CHROME) Study Group.
    Cephalalgia; 2007 Jul 25; 27(7):814-23. PubMed ID: 17441971
    [Abstract] [Full Text] [Related]

  • 6. Topiramate in migraine prevention: a double-blind, placebo-controlled study.
    Storey JR, Calder CS, Hart DE, Potter DL.
    Headache; 2001 Jul 25; 41(10):968-75. PubMed ID: 11903524
    [Abstract] [Full Text] [Related]

  • 7. Topiramate versus amitriptyline in migraine prevention: a 26-week, multicenter, randomized, double-blind, double-dummy, parallel-group noninferiority trial in adult migraineurs.
    Dodick DW, Freitag F, Banks J, Saper J, Xiang J, Rupnow M, Biondi D, Greenberg SJ, Hulihan J, CAPSS-277 Investigator Group.
    Clin Ther; 2009 Mar 25; 31(3):542-59. PubMed ID: 19393844
    [Abstract] [Full Text] [Related]

  • 8. Topiramate in migraine prevention: results of a large controlled trial.
    Silberstein SD, Neto W, Schmitt J, Jacobs D, MIGR-001 Study Group.
    Arch Neurol; 2004 Apr 25; 61(4):490-5. PubMed ID: 15096395
    [Abstract] [Full Text] [Related]

  • 9. Long-term migraine prevention with topiramate: open-label extension of pivotal trials.
    Rapoport A, Mauskop A, Diener HC, Schwalen S, Pfeil J.
    Headache; 2006 Apr 25; 46(7):1151-60. PubMed ID: 16866719
    [Abstract] [Full Text] [Related]

  • 10. A double-blind, dose comparison study of topiramate for prophylaxis of basilar-type migraine in children: a pilot study.
    Lewis D, Paradiso E.
    Headache; 2007 Apr 25; 47(10):1409-17. PubMed ID: 18052950
    [Abstract] [Full Text] [Related]

  • 11. Topiramate in the prophylaxis of pediatric migraine: a double-blind placebo-controlled trial.
    Lakshmi CV, Singhi P, Malhi P, Ray M.
    J Child Neurol; 2007 Jul 25; 22(7):829-35. PubMed ID: 17715274
    [Abstract] [Full Text] [Related]

  • 12. Efficacy and tolerability of topiramate 200 mg/d in the prevention of migraine with/without aura in adults: a randomized, placebo-controlled, double-blind, 12-week pilot study.
    Silberstein SD, Hulihan J, Karim MR, Wu SC, Jordan D, Karvois D, Kamin M.
    Clin Ther; 2006 Jul 25; 28(7):1002-11. PubMed ID: 16990078
    [Abstract] [Full Text] [Related]

  • 13. The impact of migraine prevention on daily activities: a longitudinal and responder analysis from three topiramate placebo-controlled clinical trials.
    Dahlöf C, Loder E, Diamond M, Rupnow M, Papadopoulos G, Mao L.
    Health Qual Life Outcomes; 2007 Oct 04; 5():56. PubMed ID: 17916258
    [Abstract] [Full Text] [Related]

  • 14. Trial of Amitriptyline, Topiramate, and Placebo for Pediatric Migraine.
    Powers SW, Coffey CS, Chamberlin LA, Ecklund DJ, Klingner EA, Yankey JW, Korbee LL, Porter LL, Hershey AD, CHAMP Investigators.
    N Engl J Med; 2017 Jan 12; 376(2):115-124. PubMed ID: 27788026
    [Abstract] [Full Text] [Related]

  • 15. Topiramate for migraine prevention in adolescents: a pooled analysis of efficacy and safety.
    Winner P, Gendolla A, Stayer C, Wang S, Yuen E, Battisti WP, Nye JS.
    Headache; 2006 Jan 12; 46(10):1503-10. PubMed ID: 17115983
    [Abstract] [Full Text] [Related]

  • 16. Topiramate treatment of chronic migraine: a randomized, placebo-controlled trial of quality of life and other efficacy measures.
    Silberstein S, Lipton R, Dodick D, Freitag F, Mathew N, Brandes J, Bigal M, Ascher S, Morein J, Wright P, Greenberg S, Hulihan J.
    Headache; 2009 Sep 12; 49(8):1153-62. PubMed ID: 19719543
    [Abstract] [Full Text] [Related]

  • 17. Analysis of pooled data from two pivotal controlled trials on the efficacy of topiramate in the prevention of migraine.
    Freitag FG, Forde G, Neto W, Wang DZ, Schmitt J, Wu SC, Hulihan J.
    J Am Osteopath Assoc; 2007 Jul 12; 107(7):251-8. PubMed ID: 17682112
    [Abstract] [Full Text] [Related]

  • 18. Topiramate in the preventive treatment of episodic migraine: a combined analysis from pilot, double-blind, placebo-controlled trials.
    Edwards KR, Potter DL, Wu SC, Kamin M, Hulihan J.
    CNS Spectr; 2003 Jun 12; 8(6):428-32. PubMed ID: 12858132
    [Abstract] [Full Text] [Related]

  • 19. Antiepileptic drugs in migraine prevention.
    Mathew NT.
    Headache; 2001 Jun 12; 41 Suppl 1():S18-24. PubMed ID: 11903536
    [Abstract] [Full Text] [Related]

  • 20. Analysis of safety and tolerability data obtained from over 1,500 patients receiving topiramate for migraine prevention in controlled trials.
    Adelman J, Freitag FG, Lainez M, Shi Y, Ascher S, Mao L, Greenberg S, Hulihan J.
    Pain Med; 2008 Mar 12; 9(2):175-85. PubMed ID: 18298700
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.